Christopher Bravery Email and Phone Number
Christopher Bravery work email
- Valid
Christopher Bravery personal email
Experienced Regulatory Scientist (>15 years) with a primary interest in advanced therapies (ATMP, cell, gene and tissue products) and other regenerative medicine products including protein therapeutics. Providing ICH-level quality/CMC and preclinical ‘regulatory science’ support and EU regulatory procedure/law support based on a deep knowledge gained from working in both biotech and regulatory agency. Deep understanding of EU clinical trials (IMPD), EMA licensing (MAA) and post-licensing (variations) requirements gained from time as an assessor (MHRA/EMA) and supporting a wide variety of clients over many years. Principal scientific discipline is transplantation immunology (PhD) combined with experience in target validation, protein chemistry, metrology, tissue engineering, renal medicine, molecular biology, and stem cell research. Proven track record for delivering results on time (project, regulatory submission or assessment) and within budget. Proactive customer-focused service resulting in high rates of return business and customer satisfaction. Enthusiastic and self-motivated, thriving on challenge, with a high level of transferable, technical and analytical skills. Excellent communicator with considerable experience in giving presentations and workshops and training courses (biotech and ATMP) both nationally and internationally and numerous peer reviewed publications.
-
Advbiols Training CoursesConsulting On Advnaced Biological Ltd Mar 2016 - Present
-
DirectorConsulting On Advanced Biologicals Ltd Nov 2009 - Present -
Independent Non-Executive DirectorAmniotics Ab Apr 2021 - Oct 2024Lund, Skåne, Se -
DirectorEra Consulting May 2008 - Oct 2009• Primary expertise in Quality (CMC) but also provide advice/oversight of non-clinical studies/strategy and clinical strategy.• Activities include strategy documents, GAP analysis, briefing packs for scientific advice (National and EMEA) and briefing meetings (EMEA working parties), dossier compilations (MAA, IMPD, IB), expert reports/white papers and due diligence activities.• ATMP classification strategy and request submission for borderline products.• Presentations and national and international conferences and workshops.• Experience with wide array of biological products, including cytokines, growth factors and polypeptide hormones, monoclonal antibodies, enzymes, blood products, herbals, combinations products and advanced therapy medicinal products (gene therapy cell therapy and tissue engineering).• Special interests in the field of biotech process development, process validation and control, product consistency and comparability.
-
Pharmaceutical AssessorMedicines And Healthproducts Regulatory Agency 2005 - 2008• Quality (CMC) assessment of new license applications, variations and follow-up measures from predominantly centralised, but also Mutual Recognition (Decentralised) and National procedures.• 6 month secondment to clinical trials unit; Quality assessment of phase I-IV biological CTA’s.• Presentation to MHRA expert advisory groups (EAG’s) and CHM.• Attendance and presentations at BWP (EMEA). • Member of cell products working party (CPWP) at the EMEA.• Contributor to guideline drafting groups (EMEA), primarily the Cell-based medicinal products overarching guideline, also to Genetically Modified Cells guideline and Xenogeneic Cell Based Medicinal Products guideline. Provided comments on range of others.• Member of MHRA Advanced Therapy Steering Group.• Provide/draft MHRA and EMEA Scientific advice.• Provide scientific and regulatory input to MHRA borderlines group on cell-based products. Input to CHMP on cell-based borderline classifications.• Provide advice to other parts of DH on medicines issues in biotechnology. • Presentations and national and international conferences and workshops.• DTI grant assessments.
-
Senior Scientist/Team LeaderIntercytex Ltd Mar 2001 - Sep 2005R&D Team leader developing novel cell and stem cell therapies.
-
Lab HeadImutran Ltd (A Novartis Pharma Ag Co.) Feb 1998 - Mar 2001Identifying new targets for potential transgenic modifification of pigs for xenotransplantation.
-
Research AssistantHarefield Hospital 1990 - 1995
Christopher Bravery Skills
Christopher Bravery Education Details
-
Imperial College LondonXeno/Transplantation Immunology -
Brunel UniversityApplied Biochemistry
Frequently Asked Questions about Christopher Bravery
What company does Christopher Bravery work for?
Christopher Bravery works for Consulting On Advanced Biologicals Ltd
What is Christopher Bravery's role at the current company?
Christopher Bravery's current role is Consulting Regulatory Scientist.
What is Christopher Bravery's email address?
Christopher Bravery's email address is cb****@****2.co.uk
What schools did Christopher Bravery attend?
Christopher Bravery attended Imperial College London, Brunel University.
What skills is Christopher Bravery known for?
Christopher Bravery has skills like Tissue Engineering, Regenerative Medicine, Cell Therapy, Immunology, Regulatory Affairs, Cell, Gene Therapy, Monoclonal Antibodies, Biotechnology, Cell Biology, Life Sciences, Stem Cells.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial